Investors are increasingly drawn to AI tools that not only generate insights or recommendations but also autonomously execute tasks, thereby alleviating burdens on busy healthcare staff.
In a recent development, Shyld AI, a startup specializing in such AI systems, secured $13.4 million in seed funding led by Aulis Capital. Founded in Silicon Valley in 2022, Shyld AI develops intelligent devices for hospital rooms. These devices monitor activity and automatically initiate UV disinfection once a space is vacated or high-contact surfaces are touched.
The system precisely tracks movement within a room, identifies when disinfection is necessary, and then delivers targeted UV exposure. This exposure is designed to neutralize pathogens like C. diff and E. coli. Furthermore, it continuously documents cleaning activities and UV coverage, providing hospitals with clear visibility into disinfection schedules and locations.
The efficacy of Shyld’s technology was validated this year by a Stanford University study, published in the American Journal of Infection Control. The study found the system highly effective in eliminating pathogens, including C. diff, E. coli, MRSA, Staph, and Candida auris, reporting a 93% reduction in contamination compared to a control room.
Mo Noshad, CEO of Shyld AI and co-founder with his brother Morteza, emphasized the system’s rapid action, noting its ability to inactivate some pathogens in as little as 32 seconds. The platform is currently deployed in over 30 hospitals. Noshad highlights the company’s core value proposition: reducing healthcare providers’ reliance on labor-intensive workflows and mitigating the risk of hospital-acquired infections.
Noshad’s personal commitment to combating hospital-acquired infections deepened after a friend’s death from a post-surgical infection. His subsequent research and discussions with hospitals revealed that existing manual disinfection methods lacked consistency and operational efficiency. He explained, “With manual processes, there’s no way to monitor if they’re being done properly. There’s a good chance areas are missed, or chemical contact time is insufficient. Frequency is also an issue; manual disinfection is limited because it depends on labor entering the room to perform these tasks.”
Installation of Shyld’s devices is remarkably quick, taking just 15 minutes. Once mounted and plugged in, they immediately begin collecting data and autonomously disinfecting rooms. This ease of adoption facilitates rapid deployment, enabling the startup to gather extensive operational data from hospital environments.
Ultimately, the company views disinfection as an initial step into broader hospital operations intelligence. As Shyld’s devices accumulate more data, they are expected to identify issues such as missing supplies, delayed operating room turnover times, or excessive room traffic. Noshad anticipates that these insights will eventually empower Shyld to further enhance hospital efficiency and reduce infection risks.
Source link